Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Miriam Adelson, Dinita Smith & Einat Peles. (2021) Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization. Journal of Addictive Diseases 39:2, pages 226-233.
Read now
Read now
David Frank$suffix/text()$suffix/text(). (2021) “That’s No Longer Tolerated”: Policing Patients’ Use of Non-opioid Substances in Methadone Maintenance Treatment. Journal of Psychoactive Drugs 53:1, pages 10-17.
Read now
Read now
Solmaz Amiri, Robert B. Lutz, Michael G. McDonell, John M. Roll & Ofer Amram. (2020) Spatial access to opioid treatment program and alcohol and cannabis outlets: analysis of missed doses of methadone during the first, second, and third 90 days of treatment. The American Journal of Drug and Alcohol Abuse 46:1, pages 78-87.
Read now
Read now
Jamey J. Lister, Suzanne Brown, Mark K. Greenwald & David M. Ledgerwood. (2019) Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic. Substance Abuse 40:2, pages 185-193.
Read now
Read now
Dian-Jeng Li, Kuan-Shang Chung, Hung-Chi Wu, Chih-Yao Hsu & Cheng-Fang Yen. (2018) Predictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan. Neuropsychiatric Disease and Treatment 14, pages 2853-2859.
Read now
Read now
Steven L. Proctor, Amy L. Copeland, Albert M. Kopak, Norman G. Hoffmann, Philip L. Herschman & Nadiya Polukhina. (2016) Outcome predictors for patients receiving methadone maintenance treatment: findings from a retrospective multi-site study. Journal of Substance Use 21:6, pages 601-613.
Read now
Read now
Einat Peles, Shirley Linzy, Anat Sason, Oren Tene & Miriam Adelson. (2015) Is Internet Addiction Prevalent Among Methadone Maintenance Treatment Patients? Data from Las Vegas and Tel Aviv. Journal of Addictive Diseases 34:4, pages 296-302.
Read now
Read now
Miriam Schiff, Nitsa Nacasch, Shabtay Levit, Noam Katz & Edna B. Foa. (2015) Prolonged Exposure for Treating PTSD Among Female Methadone Patients Who Were Survivors of Sexual Abuse in Israel. Social Work in Health Care 54:8, pages 687-707.
Read now
Read now
Michel Perreault, Dominic Julien, Noe Djawn White, Daniel Rabouin, Pierre Lauzon & Diana Milton. (2015) Psychological Predictors of Retention in a Low-Threshold Methadone Maintenance Treatment for Opioid Addicts: A 1-Year Follow-Up Study. Substance Use & Misuse 50:1, pages 24-31.
Read now
Read now
Einat Peles, Shaul Schreiber, Yoav Domany & Miriam Adelson. (2014) Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment. The World Journal of Biological Psychiatry 15:8, pages 629-635.
Read now
Read now
Miriam Adelson, Hon
Wai Wilson, Vong
Yim Mui Celeste, Shirley Linzy, Mary
Jeanne Kreek & Einat Peles. (2013) Methadone Maintenance Treatment Experience in Macao – Prospective Follow-up for Initial 4.5 Years. Journal of Psychoactive Drugs 45:4, pages 313-321.
Read now
Read now
Huang-Chi Lin, Yu-Ping Chang, Peng-Wei Wang, Hung-Chi Wu, Chia-Nan Yen, Yi-Chun Yeh, Kuan-Sheng Chung, Hsun-Cheng Chang & Cheng-Fang Yen. (2013) Gender Differences in Heroin Users Receiving Methadone Maintenance Therapy in Taiwan. Journal of Addictive Diseases 32:2, pages 140-149.
Read now
Read now
Diane S. Morse, Miriam Schiff, Shabtay Levit, Rinat Cohen-Moreno, Geoffrey C. Williams & Yehuda Neumark. (2012) A Pilot Training Program for a Motivational Enhancement Approach to Hepatitis C Virus Treatment Among Individuals in Israeli Methadone Treatment Centers. Substance Use & Misuse 47:1, pages 56-66.
Read now
Read now
Articles from other publishers (42)
Cayley Russell, Justine Law, Sameer Imtiaz, Jürgen Rehm, Bernard Le Foll & Farihah Ali. (2023) The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2023) Malmö Treatment Referral and Intervention Study (MATRIS)—36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment—The role of stimulant use at baseline. Journal of Substance Use and Addiction Treatment 151, pages 209036.
Crossref
Crossref
Haley Breland, Sherry Larkins, Valerie Antonini, Thomas Freese, Mark McGovern, Julia Dunn & Richard Rawson. (2023) Stimulant use among patients in opioid treatment settings: Provider perspectives. Journal of Substance Use and Addiction Treatment 151, pages 209012.
Crossref
Crossref
Zishan Cui, Mohammad Karamouzian, Michael Law, Kanna Hayashi, M-J Milloy & Thomas Kerr. (2023) The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis. International Journal of Mental Health and Addiction.
Crossref
Crossref
Thuong Nong, Dominic Hodgkin, Nguyen Thu Trang, Steven J. Shoptaw, Michael J. Li, Hoang Thi Hai Van & Giang Le. (2023) A review of factors associated with methadone maintenance treatment adherence and retention in Vietnam. Drug and Alcohol Dependence 243, pages 109699.
Crossref
Crossref
Farah Tahsin, Kristen A. Morin, Frank Vojtesek & David C. Marsh. (2022) Measuring treatment attrition at various stages of engagement in Opioid Agonist Treatment in Ontario Canada using a cascade of care framework. BMC Health Services Research 22:1.
Crossref
Crossref
Damas A. Mlaki, Jessie K. Mbwambo, Sheryl McCurdy, Frank A. Masao & Pamela A. Kaduri. (2022) Twelve-month Treatment Retention and Associated Factors: A Comparison of 2 Medically Assisted Therapy Clinics in Dar es Salaam, Tanzania. Journal of Addiction Medicine 16:6, pages e382-e389.
Crossref
Crossref
Kristen A Morin, John R Dabous, Frank Vojtesek & David Marsh. (2022) Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study. BMJ Open 12:10, pages e060857.
Crossref
Crossref
Megan Kurz, Jeong Eun Min, Laura M. Dale & Bohdan Nosyk. (2022) Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada. Journal of Substance Abuse Treatment 133, pages 108647.
Crossref
Crossref
Kristen A. Morin, Frank Vojtesek, Shreedhar Acharya & David C. Marsh. (2021) Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada. Frontiers in Psychiatry 12.
Crossref
Crossref
Madeline C. Frost, Hannah Lampert, Judith I. Tsui, Matthew D. Iles-Shih & Emily C. Williams. (2021) The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addiction Science & Clinical Practice 16:1.
Crossref
Crossref
Martin Busch, Charlotte Klein, Alfred Uhl, Hans Haltmayer, Maurice Cabanis, Jean Nicolas Westenberg, Marc Vogel & R. Michael Krausz. (2021) Retention in the Austrian opioid agonist treatment system: a national prospective cohort study. Harm Reduction Journal 18:1.
Crossref
Crossref
Chrianna Bharat, Sarah Larney, Sebastiano Barbieri, Timothy Dobbins, Nicola R. Jones, Matthew Hickman, Natasa Gisev, Robert Ali & Louisa Degenhardt. (2021) The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study. Addiction 116:11, pages 3139-3152.
Crossref
Crossref
Lindsay Mackay, Paxton Bach, M-J Milloy, Zishan Cui, Thomas Kerr & Kanna Hayashi. (2021) The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs. Drug and Alcohol Dependence 225, pages 108844.
Crossref
Crossref
Kristen A. Morin, Matthiew D. Parrotta, Joseph K. Eibl & David C. Marsh. (2021) A Retrospective Cohort Study Comparing In-Person and Telemedicine-Based Opioid Agonist Treatment in Ontario, Canada, Using Administrative Health Data. European Addiction Research 27:4, pages 268-276.
Crossref
Crossref
Kristen A. Morin, Joseph K. Eibl, Graham Gauthier, Brian Rush, Christopher Mushquash, Nancy E. Lightfoot & David C. Marsh. (2020) A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health data. Harm Reduction Journal 17:1.
Crossref
Crossref
Stephanie Lake & Michelle St. Pierre. (2020) The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review. Clinical Psychology Review 82, pages 101939.
Crossref
Crossref
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, Joe Barry & Fiona Boland. (2020) Retention of patients in opioid substitution treatment: A systematic review. PLOS ONE 15:5, pages e0232086.
Crossref
Crossref
Kristen A. Morin, Chad R. Prevost, Joseph K. Eibl, Michael T. Franklyn, Alexander R. Moise & David C. Marsh. (2020) A retrospective cohort study evaluating correlates of deep tissue infections among patients enrolled in opioid agonist treatment using administrative data in Ontario, Canada. PLOS ONE 15:4, pages e0232191.
Crossref
Crossref
Mirinda Ann Gormley, Courtney T Blondino, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Elizabeth C Prom-Wormley & Juan Lu. (2020) Assessment of Co-Occurring Substance Use During Opiate Treatment Programs in the United States. Epidemiologic Reviews 42:1, pages 79-102.
Crossref
Crossref
Courtney T Blondino, Mirinda Ann Gormley, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Juan Lu & Elizabeth C Prom-Wormley. (2020) The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type. Epidemiologic Reviews 42:1, pages 57-78.
Crossref
Crossref
Heather McBrien, Candice Luo, Nitika Sanger, Laura Zielinski, Meha Bhatt, Xi Ming Zhu, David C. Marsh, Lehana Thabane & Zainab Samaan. (2019) Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ Open 7:4, pages E665-E673.
Crossref
Crossref
Solmaz Amiri, Katherine Hirchak, Robert Lutz, Michael G. McDonell, Sterling M. McPherson, John M. Roll & Ofer Amram. (2018) Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets. Drug and Alcohol Dependence 193, pages 63-68.
Crossref
Crossref
Graham Gauthier, Joseph K. Eibl & David C. Marsh. (2018) Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies. Drug and Alcohol Dependence 191, pages 1-5.
Crossref
Crossref
Pham Minh Khue, Nguyen Thi Tham, Dinh Thi Thanh Mai, Pham Van Thuc, Vu Minh Thuc, Pham Van Han & Christina Lindan. (2017) A longitudinal and case-control study of dropout among drug users in methadone maintenance treatment in Haiphong, Vietnam. Harm Reduction Journal 14:1.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham Gauthier, David Pellegrini, Nancy E. Lightfoot & David C. Marsh. (2017) The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduction Journal 14:1.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham J. Gauthier, David Pellegrini, Nancy E. Lightfoot & David C. Marsh. (2017) The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada. International Journal of Drug Policy 48, pages 1-8.
Crossref
Crossref
Jamey J. Lister, Mark K. Greenwald & David M. Ledgerwood. (2017) Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone. Journal of Substance Abuse Treatment 78, pages 15-21.
Crossref
Crossref
Kaina Zhou, Hengxin Li, Xiaoli Wei, Xiaomei Li & Guihua Zhuang. (2017) Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi’an, China. Journal of Addiction Medicine 11:1, pages 28-33.
Crossref
Crossref
Paxton BachGeoffrey WaltonKanna HayashiM-J MilloyHuiru DongThomas KerrJulio MontanerEvan Wood. (2016) Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs. American Journal of Public Health 106:6, pages 1067-1072.
Crossref
Crossref
Joseph K. Eibl, Tara Gomes, Diana Martins, Ximena Camacho, David N. Juurlink, Muhammad M. Mamdani, Irfan A. Dhalla & David C. Marsh. (2015) Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada. Journal of Addiction Medicine 9:6, pages 440-446.
Crossref
Crossref
Amanda R. Levine, Leslie H. Lundahl, David M. Ledgerwood, Michael Lisieski, Gary L. Rhodes & Mark K. Greenwald. (2015) Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment. Journal of Substance Abuse Treatment 54, pages 37-43.
Crossref
Crossref
Einat Peles, Shaul Schreiber, Shirley Linzy, Yoav Domani & Miriam Adelson. (2015) Differences in Methylphenidate Abuse Rates Among Methadone Maintenance Treatment Patients in Two Clinics. Journal of Substance Abuse Treatment 54, pages 44-49.
Crossref
Crossref
Walter Ling. (2013)
Commentary on Brooner
et al
. (2013): One-stop shopping-what sells and what doesn't
. Addiction 108:11, pages 1952-1953.
Crossref
Crossref
Einat Peles, Shirley Linzy, Mary Jeanne Kreek & Miriam Adelson. (2013) Prospective Study of QTc Changes Among Former Opiate Addicts Since Admission to Methadone Maintenance Treatment. Journal of Addiction Medicine 7:6, pages 428-434.
Crossref
Crossref
Xiaoli Wei, Lirong Wang, Xueliang Wang, Jinsong Li, Hengxin Li & Wei Jia. (2013) A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi'an. Journal of Addiction Medicine 7:5, pages 342-348.
Crossref
Crossref
Shih-Hsien Lin, Wei Tseng Chen, Kao Chin Chen, Sheng-Yu Lee, I. Hui Lee, Po See Chen, Tzung Lieh Yeh, Ru-Band Lu & Yen Kuang Yang. (2013) Associations Among Hypothalamus-Pituitary-Adrenal Axis Function, Novelty Seeking, and Retention in Methadone Maintenance Therapy for Heroin Dependency. Journal of Addiction Medicine 7:5, pages 335-341.
Crossref
Crossref
Einat Peles, Shaul Schreiber, Vera Rados & Miriam Adelson. (2011) Low Risk for Hepatitis C Seroconversion in Methadone Maintenance Treatment. Journal of Addiction Medicine 5:3, pages 214-220.
Crossref
Crossref
Sharon M. Kelly, Kevin E. O’Grady, Shannon Gwin Mitchell, Barry S. Brown & Robert P. Schwartz. (2011) Predictors of methadone treatment retention from a multi-site study: A survival analysis. Drug and Alcohol Dependence 117:2-3, pages 170-175.
Crossref
Crossref
George H. Trksak, J. Eric Jensen, David T. Plante, David M. Penetar, Wendy L. Tartarini, Melissa A. Maywalt, Michael Brendel, Cynthia M. Dorsey, Perry F. Renshaw & Scott E. Lukas. (2010) Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: A [31]P MRS brain imaging study. Drug and Alcohol Dependence 106:2-3, pages 79-91.
Crossref
Crossref
Alex K. Elkader, Bruna Brands, Russell Callaghan & Beth A. Sproule. (2009) Exploring the relationship between perceived inter-dose opioid withdrawal and patient characteristics in methadone maintenance treatment. Drug and Alcohol Dependence 105:3, pages 209-214.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2022) Malmö Treatment Referral and Intervention Study (MATRIS)—36-Month Follow-Up on Retention and Substance Use Among Patients Referred from a Needle Exchange Program to Opioid Substitution Treatment. SSRN Electronic Journal.
Crossref
Crossref